Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Yahoo! Finance
Maravai LifeSciences Holdings Inc ( NASDAQ:MRVI ) reported $65 million in revenue for Q3 2024, with $50 million coming from the Nucleic Acid Production (NAP) segment. The company achieved a key milestone by completing its largest service build to date, producing 26 grams of mRNA material for a preclinical cell and gene therapy customer. Maravai LifeSciences Holdings Inc ( NASDAQ:MRVI ) has introduced 21 new products year-to-date, expanding its discovery mRNA synthesis services offerings. The company has expanded its TriLink-owned IP around co-transcriptional capping technology, holding over 20 US and international patents. Maravai LifeSciences Holdings Inc ( NASDAQ:MRVI ) has signed a definitive agreement to acquire the DNA and RNA businesses of PCNA BiTE, enhancing its mRNA offering for early-phase discovery work. Q3 2024 results were slightly below expectations due to customer-requested program timing shifts and muted demand in research and discovery products. The compa
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- Maravai LifeSciences Announces November 2024 Investor Conference ScheduleGlobeNewswire
- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target lowered by analysts at Royal Bank of Canada from $17.00 to $13.00. They now have an "outperform" rating on the stock.MarketBeat
- Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
MRVI
Earnings
- 11/7/24 - Beat
MRVI
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form 4
- 11/13/24 - Form SC
- MRVI's page on the SEC website